MARKERS OF PERIPHERAL NERVOUS SYSTEM LESION IN DIABETES MELLITUS
https://doi.org/10.21518/2079-701X-2017-11-23-26
Abstract
The article is devoted to the diabetic polyneuropathy – frequency, possibilities of diagnostics, including those with use of instrumental methods. Own data about possibilities to detect asymptomatic lesion of the peripheral nervous system in diabetes mellitus patients are provided. Effectiveness of the therapy of this state with the help of one of the drugs of the thioctic acid based drugs (Berlithione®).
About the Authors
О. V. Kurushina
Volgograd State Medical University
Russian Federation
Russian Federation
MD
A. Е. Barulin
Volgograd State Medical University
Russian Federation
MD
Russian Federation
MD
D. V. Karpukhina
Volgograd State Medical University
Russian Federation
Russian Federation
References
1. Аметов А.C., Строков И.А., Самигуллин Р. Антиоксидантная терапия диабетической полинейропатии. РМЖ, 2005, 13(6): 339-43.
2. Антонова К. В., Недосугова Л. В., Балаболкин М. М. и др. Влияние компенсации углеводного обмена на свободнорадикальное окисление липопротеидов низкой плотности и активности ферментативной антиоксидантной системы при сахарном диабете типа 2. Проблемы эндокринологии, 2003, 49(2)6 1-4.
3. Диабетическая периферическая сенсомоторная полинейропатия. Патогенез, клиника, диагностика. Методические рекомендации. М., 2000.
4. Курушина О.В., Барулин А.Е. Полинейропатии при соматических заболеваниях: роль невролога в диагностике и лечении. РМЖ, 2013, 31(36): 1843-1848.
5. Левин О.С. Полиневропатии. М.: Медицинское информационное агентство. 2016. 156 с.
6. Храмилин В.Н. Диабетическая нейропатия. М.: Издательский дом Видар-М, 2012. 7 с.
7. Gurieva IV, Komelyagina EU, Kuzina IV. Effects of short course treatment with antioxidant lipoic acid in diabetic foot and diabetic foot risk group patients. Joint Meeting of Neurodiab and Diabetic Foot Study Group of the EASD. 2000. P. 23.
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compare with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998, 352: 837-853.
9. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with antioxidant α-lipoic acid: a meta-analysis. Diabetic Medicine, 2004, 21: 114-21.
Review
For citations:
Kurushina ОV, Barulin AЕ, Karpukhina DV. MARKERS OF PERIPHERAL NERVOUS SYSTEM LESION IN DIABETES MELLITUS. Meditsinskiy sovet = Medical Council. 2017;(11):23-26. (In Russ.) https://doi.org/10.21518/2079-701X-2017-11-23-26
Views:
764
Email this article 